Iradimed Co Stock Odds of Future Stock Price Finishing Under 49.84
| IRMD Stock | USD 52.33 0.67 1.26% |
Iradimed |
Iradimed Target Price Odds to finish below 49.84
The tendency of Iradimed Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 49.84 or more in 90 days |
| 52.33 | 90 days | 49.84 | about 21.76 |
Based on a normal probability distribution, the odds of Iradimed to drop to $ 49.84 or more in 90 days from now is about 21.76 (This Iradimed Co probability density function shows the probability of Iradimed Stock to fall within a particular range of prices over 90 days) . Probability of Iradimed price to stay between $ 49.84 and its current price of $52.33 at the end of the 90-day period is about 37.14 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.5 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Iradimed will likely underperform. Additionally Iradimed Co has an alpha of 0.0974, implying that it can generate a 0.0974 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Iradimed Price Density |
| Price |
Predictive Modules for Iradimed
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Iradimed. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Iradimed Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Iradimed is not an exception. The market had few large corrections towards the Iradimed's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Iradimed Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Iradimed within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.1 | |
β | Beta against Dow Jones | 1.50 | |
σ | Overall volatility | 2.48 | |
Ir | Information ratio | 0.05 |
Iradimed Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Iradimed for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Iradimed can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| About 57.0% of the company shares are owned by institutional investors | |
| On 25th of November 2024 Iradimed paid $ 0.15 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Infusion Pump Market Expected To Reach 21.44 Billion 2032, Growing at CAGR 4.9 percent Introspective Market Research |
Iradimed Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Iradimed Stock often depends not only on the future outlook of the current and potential Iradimed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Iradimed's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.7 M | |
| Cash And Short Term Investments | 49.8 M |
Iradimed Technical Analysis
Iradimed's future price can be derived by breaking down and analyzing its technical indicators over time. Iradimed Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Iradimed Co. In general, you should focus on analyzing Iradimed Stock price patterns and their correlations with different microeconomic environments and drivers.
Iradimed Predictive Forecast Models
Iradimed's time-series forecasting models is one of many Iradimed's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Iradimed's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Iradimed
Checking the ongoing alerts about Iradimed for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Iradimed help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| About 57.0% of the company shares are owned by institutional investors | |
| On 25th of November 2024 Iradimed paid $ 0.15 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Infusion Pump Market Expected To Reach 21.44 Billion 2032, Growing at CAGR 4.9 percent Introspective Market Research |
Check out Iradimed Backtesting, Iradimed Valuation, Iradimed Correlation, Iradimed Hype Analysis, Iradimed Volatility, Iradimed History as well as Iradimed Performance. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iradimed. If investors know Iradimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iradimed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0) | Dividend Share 0.45 | Earnings Share 1.46 | Revenue Per Share 5.635 | Quarterly Revenue Growth 0.11 |
The market value of Iradimed is measured differently than its book value, which is the value of Iradimed that is recorded on the company's balance sheet. Investors also form their own opinion of Iradimed's value that differs from its market value or its book value, called intrinsic value, which is Iradimed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iradimed's market value can be influenced by many factors that don't directly affect Iradimed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iradimed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Iradimed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iradimed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.